0
Sign In  | Subscribe
3 February 2009, Vol 150, No. 3>
Summaries for Patients | 3 February 2009

Immunochemical Fecal Occult Blood Tests FREE

[+] Article and Author Information

The summary below is from the full report titled “Comparative Evaluation of Immunochemical Fecal Occult Blood Tests for Colorectal Adenoma Detection.” It is in the 3 February 2009 issue of Annals of Internal Medicine (volume 150, pages 162-169). The authors are S. Hundt, U. Haug, and H. Brenner.


Ann Intern Med. 2009;150(3):I-34. doi:10.7326/0003-4819-150-3-200902030-00002
Text Size: A A A

What is the problem and what is known about it so far?

Screening for colorectal cancer can lower the risk for dying of colorectal cancer by finding growths (adenomas) before they become cancer or by finding cancer at an early, curable stage. One commonly used screening test for colorectal lesions is the fecal occult blood test (FOBT). The traditional guaiac-based FOBT uses a chemical reaction on a paper card to find traces of blood that leak from adenomas and cancer into the stool. The guaiac-based FOBT result can be positive when there is no source of bleeding (false-positive) if, for example, a person has recently eaten undercooked meats. The guaiac-based FOBT result may also be negative when there is a source of bleeding (false-negative) if a person has been taking vitamin C supplements.

Several new immunochemical FOBTs use specific antibodies against human blood components to detect traces of blood in the stool. Some of these newer tests may have fewer false-positive and false-negative results than the guaiac-based FOBT. However, many immunochemical FOBTs use different antibodies to detect blood components, and we do not know whether they all have similar ability to detect precancerous lesions that leak blood into the stool.

Why did the researchers do this particular study?

To compare characteristics of 6 qualitative immunochemical FOBTs and 1 guaiac-based FOBT for identifying colorectal adenomas in adults at average risk for colorectal cancer.

Who was studied?

1319 adults who attended screening colonoscopy examinations. None had symptoms of colorectal cancer.

How was the study done?

All patients brought a single guaiac-based test card and a stool sample that had been collected at home to their clinic visits. Physician assistants analyzed the test cards. The stool samples were frozen and sent to a central laboratory for immunochemical analysis. All patients then had a complete examination of the colon with a flexible tube (colonoscopy) to look for polyps and cancer. Persons who analyzed FOBTs did not know colonoscopy results. Physicians who did the colonoscopies did not know FOBT results.

What did the researchers find?

The FOBTs varied widely in their ability to detect adenomas that were found with colonoscopy. Sensitivity and specificity for detecting advanced adenoma ranged from 25% to 72% and from 70% to 97% for the 6 qualitative immunochemical tests. The sensitivity and specificity of the guaiac-based test for detecting advanced adenoma were 9% and 96%.

What were the limitations of the study?

Stool samples from 1 day rather than several days were used. Stool was frozen before immunochemical testing. Colonoscopy may have failed to detect colorectal cancer or large polyps in some patients.

What are the implications of the study?

Qualitative immunochemical FOBTs vary markedly in their ability to detect precancerous colorectal lesions. Some, but not all, of these newer tests may be promising alternatives to guaiac-based FOBTs.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general jounals
BMJ 2010;341:c5893-c1494.

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Advertisement

Related Content

Customize your page view by dragging & repositioning the boxes below.

Topic Collections
PubMed Articles
New strategies for colorectal cancer screening.
World journal of gastroenterology : WJG Issue date: 2013 Mar 28
Faecal haemoglobin concentration is related to severity of colorectal neoplasia.
Journal of clinical pathology Issue date: 2013 May

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)